Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Onconova Therapeutic (ONTX)

Onconova Therapeutic (ONTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 22,777
  • Shares Outstanding, K 20,896
  • Annual Sales, $ 230 K
  • Annual Income, $ -16,160 K
  • 60-Month Beta 1.80
  • Price/Sales 103.42
  • Price/Cash Flow N/A
  • Price/Book 0.55
Trade ONTX with:

Options Overview Details

View History
  • Implied Volatility 480.96% ( +304.53%)
  • Historical Volatility 60.92%
  • IV Percentile 99%
  • IV Rank 95.90%
  • IV High 498.62% on 04/22/22
  • IV Low 67.78% on 12/23/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 5
  • Put/Call OI Ratio 0.11
  • Today's Open Interest 950
  • Open Int (30-Day) 921

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.20
  • Number of Estimates 1
  • High Estimate -0.20
  • Low Estimate -0.20
  • Prior Year -0.27
  • Growth Rate Est. (year over year) +25.93%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0000 +9.00%
on 05/12/22
1.5500 -29.68%
on 04/21/22
-0.3900 (-26.35%)
since 04/20/22
3-Month
1.0000 +9.00%
on 05/12/22
2.0400 -46.57%
on 03/28/22
-0.5300 (-32.72%)
since 02/18/22
52-Week
1.0000 +9.00%
on 05/12/22
10.8400 -89.94%
on 05/21/21
-9.8600 (-90.05%)
since 05/20/21

Most Recent Stories

More News
Regulus (RGLS) Up as FDA Accepts IND for Kidney Disease Drug

The FDA accepts Regulus' (RGLS) IND application for RGLS8429 to treat autosomal dominant polycystic kidney disease. The company plans to begin a phase I study in second-quarter 2022. Stock up.

SNY : 54.40 (+2.53%)
RGLS : 0.2261 (+7.62%)
ONTX : 1.0900 (-2.55%)
SLNO : 0.1840 (+2.56%)
Onconova Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update

Conference call and live webcast at 4:30 p.m. ET today...

ONTX : 1.0900 (-2.55%)
Catalyst Pharmaceuticals (CPRX) Q1 Earnings Miss, Revenues Up Y/Y

Catalyst's (CPRX) first-quarter 2022 earnings miss estimates while revenues meet the same.

CPRX : 7.06 (+2.02%)
GALT : 1.2800 (-3.03%)
ONTX : 1.0900 (-2.55%)
SLNO : 0.1840 (+2.56%)
Collegium Pharmaceutical (COLL) Lags Q1 Earnings Estimates

Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of -38.14% and 6.41%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?...

COLL : 16.36 (+2.38%)
ONTX : 1.0900 (-2.55%)
Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -40% and 6.62%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

HRTX : 3.60 (+0.84%)
ONTX : 1.0900 (-2.55%)
Theravance Biopharma (TBPH) Reports Q1 Loss, Lags Revenue Estimates

Theravance Bio (TBPH) delivered earnings and revenue surprises of -100% and 20.07%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

TBPH : 8.74 (-1.24%)
ONTX : 1.0900 (-2.55%)
Onconova (ONTX) to Report Q1 Earnings: What's in the Cards?

Investors will watch for updates on its lead candidate narazaciclib when Onconova Therapeutics. (ONTX) reports first-quarter earnings.

VRTX : 258.59 (+1.23%)
JAZZ : 148.53 (-0.67%)
CLVS : 0.7130 (-0.04%)
ONTX : 1.0900 (-2.55%)
Onconova Therapeutics Announces Acceptance of Abstract for Publication at the ASCO Annual Meeting

NEWTOWN, Pa., April 27, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on...

ONTX : 1.0900 (-2.55%)
Corcept (CORT) Posts OS Data from Phase II Ovarian Cancer Study

Corcept (CORT) posts overall survival data from a phase II study evaluating relacorilant plus nab-paclitaxel for treating recurrent platinum-resistant ovarian cancer.

MRK : 93.55 (+1.59%)
CORT : 20.42 (+0.84%)
ONTX : 1.0900 (-2.55%)
CRBP : 0.3410 (-1.93%)
Onconova Therapeutics to Present at the Next Generation Kinase Inhibitors Summit

NEWTOWN, Pa., March 23, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on...

ONTX : 1.0900 (-2.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Onconova Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecule drug candidates to treat cancer. The Company's products under different phases of development include Rigosertib intravenous (IV), Rigosertib Oral, Rigosertib IV,...

See More

Key Turning Points

3rd Resistance Point 1.2415
2nd Resistance Point 1.1952
1st Resistance Point 1.1426
Last Price 1.0900
1st Support Level 1.0437
2nd Support Level 0.9974
3rd Support Level 0.9448

See More

52-Week High 10.8400
Fibonacci 61.8% 7.0811
Fibonacci 50% 5.9200
Fibonacci 38.2% 4.7589
Last Price 1.0900
52-Week Low 1.0000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar